Benzimidazoles and their derivatives play an extraordinarily significant role as therapeutic
agents, eg, antiulcer, analgesic, and anthelmintic drugs. The organic synthesis of …

A new generation of antithrombotic agents, which are conventionally known as direct oral
anticoagulants (DOACs), have recently emerged and are continuing to be developed. These …

Introduction: Atrial fibrillation (AF) is increasing in prevalence and is associated with
significant morbidity and mortality. The optimal diagnostic and treatment strategies for AF are …

Background Enhanced Recovery After Surgery (ERAS) protocols reduce length of stay,
complications and costs for a large number of elective surgical procedures. A similar …

Background Direct‐acting oral anticoagulants (DOAC s) are used in patients with splanchnic
vein thrombosis (SVT) and cirrhosis, but evidence for safety and efficacy in this setting is …

Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in
mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050 …

Introduction The purpose of this study is to compare the effect of increasing concentrations of
direct anti‐Xa oral anticoagulants (DOAC) apixaban‐, edoxaban‐, and rivaroxaban …

The direct oral anticoagulants (DOACs), now including dabigatran, apixaban and
rivaroxaban, have given clinicians alternative options to low molecular weight heparins …

Background. Newer oral anticoagulants (NOACs) are being utilized increasingly for the
treatment of venous thromboembolism (VTE). NOAC use is the standard of care for stroke …

Spontaneous non-traumatic intracerebral hemorrhage (ICH) remains a significant cause of
mortality and morbidity throughout the world. To improve the devastating course of ICH …